Suspension of trading

Balance Sheet Numinus Wellness Inc. Toronto S.E.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 11:00:00 2026-01-21 am EST			5-day change	1st Jan Change
0.0500 ^CAD	-.--%		-.--%	-

d88aef.ZerCvV4mskC-e3OA1bbcK4-IBNpvNpr2VTOOTwIRDVA.V936zjhs1gXJKgv0t--5YcT8foMae8yjYgrkP2hZOgI1g_r8P3mfFOk9Ng

Published financial data: NUMINUS WELLNESS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: August	2020	2021	2022	2023	2024
Revenues	881K	1.51M	6.49M	23.18M	4.17M
Total Revenues	881K	1.51M	6.49M	23.18M	4.17M
Cost of Goods Sold, Total	798K	1.6M	4.72M	14.81M	3M
Gross Profit	82.96K	-81.54K	1.78M	8.37M	1.17M
Selling General & Admin Expenses, Total	5.04M	12.09M	23.91M	29.53M	11.78M
Provision for Bad Debts	-	-	-	565K	209K
Stock-Based Compensation (IS)	1.88M	1.82M	3.45M	1.87M	563K
R&D Expenses	18.35K	1.4M	1.89M	1.17M	26.35K
Depreciation & Amortization - (IS)	432K	445K	982K	1.64M	502K
Other Operating Expenses, Total	7.37M	15.76M	30.23M	34.77M	13.08M
Operating Income	-7.28M	-15.84M	-28.45M	-26.4M	-11.92M
Interest Expense, Total	-144K	-114K	-558K	-760K	-98.78K
Interest And Investment Income	8.73K	-	129	9.34K	7.71K
Net Interest Expenses	-135K	-114K	-558K	-750K	-91.07K
Currency Exchange Gains (Loss)	-	-	212K	-73.58K	-64.3K
Other Non Operating Income (Expenses)	19.74K	-35.72K	13.93K	-535K	108K
EBT, Excl. Unusual Items	-7.4M	-15.99M	-28.78M	-27.75M	-11.96M
Restructuring Charges	-	-	-	-564K	-
Merger & Related Restructuring Charges	-	-266K	-2.52M	-	-
Impairment of Goodwill	-	-1.58M	-13.23M	-2.28M	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-1.23M
Gain (Loss) On Sale Of Assets	40.36K	1.26K	-	-	-931K
Asset Writedown	-	-897K	-368K	-268K	-174K
Other Unusual Items	-2.25M	-40K	-17.54K	612K	-301K
EBT, Incl. Unusual Items	-9.61M	-18.77M	-44.92M	-30.26M	-14.6M
Income Tax Expense	-7.88K	-	-34K	-	-
Earnings From Continuing Operations	-9.6M	-18.77M	-44.88M	-30.26M	-14.6M
Earnings Of Discontinued Operations	-	-	-	-	-5.04M
Net Income to Company	-9.6M	-18.77M	-44.88M	-30.26M	-19.64M
Net Income - (IS)	-9.6M	-18.77M	-44.88M	-30.26M	-19.64M
Net Income to Common Incl Extra Items	-9.6M	-18.77M	-44.88M	-30.26M	-19.64M
Net Income to Common Excl. Extra Items	-9.6M	-18.77M	-44.88M	-30.26M	-14.6M
Per Share Items
Net EPS - Basic	-0.15	-0.11	-0.18	-0.11	-0.07
Basic EPS - Continuing Operations	-0.15	-0.11	-0.18	-0.11	-0.05
Basic Weighted Average Shares Outstanding	63.81M	165M	256M	264M	295M
Net EPS - Diluted	-0.15	-0.11	-0.18	-0.11	-0.07
Diluted EPS - Continuing Operations	-0.15	-0.11	-0.18	-0.11	-0.05
Diluted Weighted Average Shares Outstanding	63.81M	165M	256M	264M	295M
Normalized Basic EPS	-0.07	-0.06	-0.07	-0.07	-0.03
Normalized Diluted EPS	-0.07	-0.06	-0.07	-0.07	-0.03
Supplemental Items
EBITDA	-6.84M	-15.47M	-27.88M	-25.4M	-11.44M
EBITA	-7.28M	-15.84M	-28.41M	-26.32M	-11.92M
EBIT	-7.28M	-15.84M	-28.45M	-26.4M	-11.92M
EBITDAR	-6.77M	-15.44M	-27.79M	-25.24M	-11.36M
Effective Tax Rate - (Ratio)	0.08	-	0.08	-	-
Current Domestic Taxes	-7.88K	-	-	-	-
Total Current Taxes	-7.88K	-	-	-	-
Total Deferred Taxes	-	-	-34K	-	-
Normalized Net Income	-4.62M	-9.99M	-17.99M	-17.35M	-7.48M
Interest on Long-Term Debt	144K	114K	558K	760K	98.78K
Supplemental Operating Expense Items
Selling and Marketing Expenses	906K	2.22M	2.19M	1.99M	771K
General and Administrative Expenses	4.13M	9.87M	21.71M	27.54M	11.01M
Research And Development Expense From Footnotes	188K	1.4M	1.89M	1.17M	26.35K
Net Rental Expense, Total	71.4K	31.44K	83.14K	163K	78.97K
Imputed Operating Lease Interest Expense	246K	28.34K	78.48K	132K	13.52K
Imputed Operating Lease Depreciation	-174K	3.1K	4.67K	31.35K	65.46K
Stock-Based Comp., Other (Total)	1.88M	1.82M	3.56M	1.87M	563K
Total Stock-Based Compensation	1.88M	1.82M	3.56M	1.87M	563K

Fiscal Period: August	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.63M	59.29M	33.04M	8.58M	1.96M
Short Term Investments	7.5K	-	-	-	-
Total Cash And Short Term Investments	1.63M	59.29M	33.04M	8.58M	1.96M
Accounts Receivable, Total	214K	46.73K	1.4M	1.77M	758K
Other Receivables	328K	469K	204K	164K	126K
Total Receivables	542K	516K	1.6M	1.94M	885K
Inventory	-	3.23K	-	-	-
Prepaid Expenses	410K	1.16M	1.48M	1.19M	571K
Other Current Assets, Total	85.14K	-	-	346K	6.39M
Total Current Assets	2.67M	60.97M	36.12M	12.05M	9.8M
Gross Property Plant And Equipment	4.15M	5.03M	14.72M	15.45M	1.38M
Accumulated Depreciation	-1.71M	-1.88M	-3.33M	-5.65M	-419K
Net Property Plant And Equipment	2.44M	3.15M	11.38M	9.8M	959K
Long-term Investments	-	-	2.37M	2.08M	-
Goodwill	-	-	2.17M	0	-
Other Intangibles, Total	-	-	343K	0	-
Other Long-Term Assets, Total	13.9K	24.66K	238K	406K	10.01K
Total Assets	5.12M	64.14M	52.63M	24.33M	10.77M
Liabilities
Accounts Payable, Total	1.5M	1.3M	2.71M	2.89M	2.02M
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	63.48K	70.68K	50.8K
Current Portion of Leases	106K	404K	1.38M	1.49M	542K
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	-	54.59K	235K	197K	198K
Other Current Liabilities	402K	150K	196K	-	5.79M
Total Current Liabilities	2.01M	1.91M	4.58M	4.64M	8.61M
Long-Term Debt	40K	-	213K	164K	155K
Long-Term Leases	276K	1.2M	6.2M	5.48M	1.29M
Other Non Current Liabilities	-	200K	425K	-	-
Total Liabilities	2.32M	3.31M	11.42M	10.28M	10.05M
Common Stock, Total	18.94M	88.87M	109M	112M	117M
Retained Earnings	-22.95M	-41.73M	-86.61M	-117M	-137M
Comprehensive Income and Other	6.82M	13.69M	18.62M	18.65M	19.82M
Total Common Equity	2.8M	60.83M	41.21M	14.05M	725K
Total Equity	2.8M	60.83M	41.21M	14.05M	725K
Total Liabilities And Equity	5.12M	64.14M	52.63M	24.33M	10.77M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	157M	204M	263M	267M	321M
ECS Total Common Shares Outstanding	95.85M	203M	256M	266M	321M
Book Value / Share	0.03	0.3	0.16	0.05	0
Tangible Book Value	2.8M	60.83M	38.7M	14.05M	725K
Tangible Book Value Per Share	0.03	0.3	0.15	0.05	0
Total Debt	422K	1.6M	7.85M	7.2M	2.03M
Net Debt	-1.21M	-57.69M	-25.19M	-1.38M	74.32K
Debt Equivalent Oper. Leases	571K	251K	665K	1.3M	632K
Account Code - Inventory Valuation	6	6	3	3	3
Machinery, Total	1.99M	1.56M	2.48M	2.58M	193K
Full Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: August	2020	2021	2022	2023	2024
Net Income	-9.6M	-18.77M	-44.88M	-30.26M	-19.64M
Depreciation & Amortization - CF	613K	717K	1.47M	2.76M	561K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	35.98K	75.4K	-
Depreciation & Amortization, Total	613K	717K	1.51M	2.83M	561K
(Gain) Loss From Sale Of Asset	-40.36K	-1.26K	108K	258K	964K
(Gain) Loss on Sale of Investments - (CF)	-1.5K	1.6K	-183K	295K	1.22M
Asset Writedown & Restructuring Costs	-	2.48M	13.28M	2.55M	174K
Stock-Based Compensation (CF)	1.88M	1.82M	3.56M	1.87M	563K
Provision and Write-off of Bad Debts	-	-	-	642K	209K
Net Cash From Discontinued Operations	-	-	-	-	-2.48M
Other Operating Activities, Total	2.3M	148K	648K	120K	5.1M
Change In Accounts Receivable	-173K	-128K	98.14K	-1.32M	296K
Change In Inventories	1.4K	-3.23K	-	-	-
Change In Accounts Payable	203K	-666K	46.36K	177K	-268K
Change in Unearned Revenues	-	54.59K	-49.73K	-37.98K	811
Change in Other Net Operating Assets	-539K	-1.23M	-360K	118K	861K
Cash from Operations	-5.36M	-15.58M	-26.23M	-22.76M	-12.43M
Capital Expenditure	-35.2K	-642K	-1.25M	-375K	-25.48K
Sale of Property, Plant, and Equipment	-	299K	-	5.88K	40.56K
Cash Acquisitions	70.7K	-402K	1.37M	-	-
Investment in Marketable and Equity Securities, Total	-	5.9K	-	-	852K
Other Investing Activities, Total	-164K	-	-	-	-7.14K
Cash from Investing	-129K	-739K	123K	-370K	860K
Short Term Debt Issued, Total	213K	-	-	-	-
Long-Term Debt Issued, Total	460K	-	-	-	-
Total Debt Issued	673K	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-348K	-334K	-684K	-2.37M	-478K
Total Debt Repaid	-348K	-334K	-684K	-2.37M	-478K
Issuance of Common Stock	6.93M	74.32M	692K	916K	5.31M
Other Financing Activities, Total	-230K	-	-	-	-287K
Cash from Financing	7.02M	73.98M	7.34K	-1.46M	4.54M
Foreign Exchange Rate Adjustments	-	-	-150K	123K	409K
Net Change in Cash	1.54M	57.67M	-26.25M	-24.46M	-6.62M
Supplemental Items
Cash Interest Paid	62.21K	108K	398K	741K	97.99K
Levered Free Cash Flow	-2.58M	-9.11M	-14.08M	-13.1M	-5.85M
Unlevered Free Cash Flow	-2.49M	-9.04M	-13.73M	-12.63M	-5.79M
Change In Net Working Capital	389K	1.03M	-231K	454K	-560K
Net Debt Issued / Repaid	325K	-334K	-684K	-2.37M	-478K

Fiscal Period: August	2020	2021	2022	2023	2024
Profitability
Return on Assets	-110.97	-28.59	-30.45	-42.87	-42.43
Return on Total Capital	-188.34	-30.16	-31.9	-46.92	-62.05
Return On Equity %	-460.92	-59.01	-87.97	-109.5	-197.64
Return on Common Equity	-460.92	-59.01	-87.97	-109.5	-197.64
Margin Analysis
Gross Profit Margin %	9.41	-5.39	27.36	36.11	27.97
SG&A Margin	571.81	798.84	368.11	127.38	282.66
EBITDA Margin %	-776.2	-1.02K	-429.28	-109.58	-274.36
EBITA Margin %	-826.43	-1.05K	-437.55	-113.54	-285.89
EBIT Margin %	-826.43	-1.05K	-438.1	-113.87	-285.89
Income From Continuing Operations Margin %	-1.09K	-1.24K	-691.12	-130.53	-350.24
Net Income Margin %	-1.09K	-1.24K	-691.12	-130.53	-471.23
Net Avail. For Common Margin %	-1.09K	-1.24K	-691.12	-130.53	-350.24
Normalized Net Income Margin	-524.68	-660.28	-277.01	-74.83	-179.39
Levered Free Cash Flow Margin	-292.29	-601.78	-216.75	-56.52	-140.38
Unlevered Free Cash Flow Margin	-282.11	-597.07	-211.38	-54.47	-138.9
Asset Turnover
Asset Turnover	0.21	0.04	0.11	0.6	0.24
Fixed Assets Turnover	0.35	0.54	0.89	2.19	0.78
Receivables Turnover (Average Receivables)	6.31	11.62	8.99	14.62	3.29
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.33	31.88	7.88	2.6	1.14
Quick Ratio	1.08	31.27	7.56	2.27	0.33
Operating Cash Flow to Current Liabilities	-2.67	-8.14	-5.72	-4.9	-1.44
Days Sales Outstanding (Average Receivables)	58.01	31.42	40.6	24.97	111.15
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	-	-	68.97	299.38
Long Term Solvency
Total Debt/Equity	15.06	2.64	19.05	51.25	280.32
Total Debt / Total Capital	13.09	2.57	16	33.88	73.71
LT Debt/Equity	11.28	1.97	15.55	40.16	198.64
Long-Term Debt / Total Capital	9.8	1.92	13.06	26.55	52.23
Total Liabilities / Total Assets	45.36	5.17	21.69	42.26	93.27
EBIT / Interest Expense	-50.74	-138.75	-51.01	-34.75	-120.65
EBITDA / Interest Expense	-46.46	-132.47	-48.31	-31.01	-100.03
(EBITDA - Capex) / Interest Expense	-46.71	-138.09	-50.54	-31.51	-100.29
Total Debt / EBITDA	-0.06	-0.11	-0.29	-0.31	-0.21
Net Debt / EBITDA	0.18	3.81	0.94	0.06	-0.01
Total Debt / (EBITDA - Capex)	-0.06	-0.1	-0.28	-0.3	-0.21
Net Debt / (EBITDA - Capex)	0.18	3.66	0.89	0.06	-0.01
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	719.87	71.78	329.03	256.95	11.08
Gross Profit, 1 Yr. Growth %	-114.91	-198.29	-2.28K	371.16	-26.81
EBITDA, 1 Yr. Growth %	10.97	126.24	80.15	-8.88	-46.71
EBITA, 1 Yr. Growth %	8.64	117.53	79.37	-7.37	-46.75
EBIT, 1 Yr. Growth %	8.64	117.53	79.6	-7.22	-46.93
Earnings From Cont. Operations, 1 Yr. Growth %	32.08	95.55	139.06	-32.59	-37.17
Net Income, 1 Yr. Growth %	32.08	95.55	139.06	-32.59	-35.08
Normalized Net Income, 1 Yr. Growth %	9.52	116.17	80.12	-3.57	-47.93
Diluted EPS Before Extra, 1 Yr. Growth %	49.21	-24.35	53.89	-44.62	-43.88
Accounts Receivable, 1 Yr. Growth %	226.68	-78.15	2.89K	26.85	-57.23
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-7.37	29.21	261.44	-13.96	-90.21
Total Assets, 1 Yr. Growth %	66.37	1.15K	-17.95	-53.77	-55.73
Tangible Book Value, 1 Yr. Growth %	104.9	2.07K	-36.38	-63.7	-94.84
Common Equity, 1 Yr. Growth %	104.9	2.07K	-32.25	-65.91	-94.84
Cash From Operations, 1 Yr. Growth %	42.41	190.89	68.37	-13.23	-45.37
Capital Expenditures, 1 Yr. Growth %	-95.98	1.72K	94.15	-69.88	-89.02
Levered Free Cash Flow, 1 Yr. Growth %	64	253.67	54.53	-6.92	-51.23
Unlevered Free Cash Flow, 1 Yr. Growth %	61.6	263.56	51.89	-8.01	-51.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-44.02	275.28	171.47	291.33	-19.88
Gross Profit, 2 Yr. CAGR %	-60.19	-61.72	362.79	913.26	-18.99
EBITDA, 2 Yr. CAGR %	68.72	58.45	101.89	28.12	-35.95
EBITA, 2 Yr. CAGR %	65.26	53.73	97.53	28.9	-35.24
EBIT, 2 Yr. CAGR %	65.26	53.73	97.66	29.08	-35.28
Earnings From Cont. Operations, 2 Yr. CAGR %	86.02	60.71	116.22	26.95	-42.97
Net Income, 2 Yr. CAGR %	86.02	60.71	116.22	26.95	-33.84
Normalized Net Income, 2 Yr. CAGR %	66.56	53.86	97.25	31.79	-35.53
Diluted EPS Before Extra, 2 Yr. CAGR %	91.99	6.25	7.9	0.41	-51.14
Accounts Receivable, 2 Yr. CAGR %	-	-15.51	155.68	516	-26.35
Inventory, 2 Yr. CAGR %	-	-29.45	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	1.36	9.4	116.11	76.34	-70.98
Total Assets, 2 Yr. CAGR %	36.96	356.39	220.5	-38.41	-54.76
Tangible Book Value, 2 Yr. CAGR %	24.72	567.25	271.8	-51.94	-86.31
Common Equity, 2 Yr. CAGR %	24.72	567.25	283.69	-51.94	-86.73
Cash From Operations, 2 Yr. CAGR %	99.69	103.53	121.31	20.87	-31.15
Capital Expenditures, 2 Yr. CAGR %	-85.86	-14.33	495.04	-23.52	-85.7
Levered Free Cash Flow, 2 Yr. CAGR %	-	140.84	133.78	19.93	-35.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	142.39	134.99	18.2	-35.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-18.65	292.4	197.41	40.17
Gross Profit, 3 Yr. CAGR %	-	-46.2	47.26	365.56	142.73
EBITDA, 3 Yr. CAGR %	-	86.05	65.38	54.86	-9.59
EBITA, 3 Yr. CAGR %	-	81.12	61.84	53.46	-9.05
EBIT, 3 Yr. CAGR %	-	81.12	61.91	53.61	-9.05
Earnings From Cont. Operations, 3 Yr. CAGR %	-	89.14	83.46	46.61	-8.04
Net Income, 3 Yr. CAGR %	-	89.14	83.46	46.61	1.52
Normalized Net Income, 3 Yr. CAGR %	-	81.69	62.12	55.39	-9.19
Diluted EPS Before Extra, 3 Yr. CAGR %	-	40.76	20.21	-8.63	-24.25
Accounts Receivable, 3 Yr. CAGR %	-	-	177.44	102.41	153.17
Inventory, 3 Yr. CAGR %	-	-58.07	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	9.91	62.94	58.98	-32.73
Total Assets, 3 Yr. CAGR %	-	186.36	157.58	68.09	-44.83
Tangible Book Value, 3 Yr. CAGR %	-	223.33	204.83	71.21	-77.15
Common Equity, 3 Yr. CAGR %	-	223.33	211.29	71.21	-77.15
Cash From Operations, 3 Yr. CAGR %	-	126.36	91.06	61.98	-7.24
Capital Expenditures, 3 Yr. CAGR %	-	-28.57	12.53	120.12	-65.89
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	107.72	71.98	-13.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	107.42	71.9	-13.79
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	52.48	107.84
Gross Profit, 5 Yr. CAGR %	-	-	-	74.09	15.95
EBITDA, 5 Yr. CAGR %	-	-	-	60.26	13.16
EBITA, 5 Yr. CAGR %	-	-	-	58.08	12.2
EBIT, 5 Yr. CAGR %	-	-	-	58.17	12.2
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	61.26	14.97
Net Income, 5 Yr. CAGR %	-	-	-	61.26	22
Normalized Net Income, 5 Yr. CAGR %	-	-	-	59.77	12.11
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	22.97	-13.28
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	63.22
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	32.79	-18.29
Total Assets, 5 Yr. CAGR %	-	-	-	54.87	28.46
Tangible Book Value, 5 Yr. CAGR %	-	-	-	50.83	-11.89
Common Equity, 5 Yr. CAGR %	-	-	-	50.83	-11.89
Cash From Operations, 5 Yr. CAGR %	-	-	-	76.12	27.02
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-26.59	-50.69
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	30.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	30.36